According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%.

According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...

Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...

BioForge and Panther Life Sciences explain how their partnership is advancing vaccine patch technology and keeping the ...

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe ...

Adults with house dust mite allergy may lose allergen-specific antibodies over time, and this decline is associated with ...

As genetic testing becomes increasingly important in modern healthcare, cytogenetics is emerging as a promising career for ...

We reviewed the options for the manufacture and use of DNA microarrays in the original Chipping Forecast 1 in 1999. Since then, the number of companies that produce microarrays equipment and reagents ...

Creative Biolabs’ integrated workflow addresses challenges in anti-glycopeptide antibody discovery, including weak ...

As the scope of proteomics is extremely broad, it is helpful to distinguish among its various aspects before discussing how microarray technology is likely to feature. Over the past decade, the ...

PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) ...